Filter Results:
(10,528)
Show Results For
- All HBS Web
(10,528)
- People (35)
- News (2,482)
- Research (6,103)
- Events (29)
- Multimedia (131)
- Faculty Publications (4,585)
Show Results For
- All HBS Web
(10,528)
- People (35)
- News (2,482)
- Research (6,103)
- Events (29)
- Multimedia (131)
- Faculty Publications (4,585)
- March 2003 (Revised June 2003)
- Case
Risk Arbitrage: Abbott Labs and Alza (A)
By: George C. Chacko, Randolph B. Cohen, Marc Chennault and Andrew Kuhlman
A hedge fund is trying to decide whether to capitalize on a seeming risk arbitrage opportunity that exists during the Abbott Labs acquisition of ALZA. View Details
Chacko, George C., Randolph B. Cohen, Marc Chennault, and Andrew Kuhlman. "Risk Arbitrage: Abbott Labs and Alza (A)." Harvard Business School Case 203-003, March 2003. (Revised June 2003.)
- 2010
- Other Unpublished Work
Share Issuance and Factor Timing
By: Robin Greenwood and Samuel Hanson
We show that characteristics of stock issuers can be used to forecast important common factors in stocks returns such as those associated with book-to-market, size, and industry. Specifically, we use differences between the attributes of stock issuers and repurchasers... View Details
Keywords: Forecasting and Prediction; Equity; Stocks; Stock Shares; Investment Return; Investment Portfolio; Price; Performance Evaluation
Greenwood, Robin, and Samuel Hanson. "Share Issuance and Factor Timing." December 2010. (Appendix. Previously titled "Characteristic Timing," NBER Working Paper Series, No. 15948.)
- 01 Dec 2016
- News
The US Patent System’s Uncertain Fate
(Illustration by Peter Arkle) What is really at stake when we talk about patents? Lauren Cohen: Innovation is the future of the US economy. Given that the value of firms is shifting toward intellectual property, if we don’t get patents right, then we’re going to be at... View Details
Keywords: April White
- November 2007 (Revised October 2009)
- Case
Ligand Pharmaceuticals Incorporated
In an activist role, the hedge fund Third Point LLC has three board seats and an ownership stake of 9.5% in Ligand Pharmaceuticals, Inc., a specialty pharmaceutical company. Third Point believed that Ligand had a strong drug portfolio and pipeline but that it was... View Details
Keywords: Mergers and Acquisitions; Private Equity; Investment Activism; Investment Funds; Governing and Advisory Boards; Bids and Bidding; Ownership Stake; Pharmaceutical Industry; United States
El-Hage, Nabil N., and Michael Gorzynski. "Ligand Pharmaceuticals Incorporated." Harvard Business School Case 208-019, November 2007. (Revised October 2009.)
- May 1998 (Revised February 2007)
- Case
Morningstar, Inc.
By: Andre F. Perold and Markus Mullarkey
Morningstar, Inc., a publisher of information for mutual fund investors, is considering alternative strategies for broadening its subscriber base and increasing its revenues. Potential strategies include tailoring information for the defined contribution pension fund... View Details
Keywords: Investment Funds; Asset Management; Revenue; Financial Strategy; Publishing Industry; Financial Services Industry; United States
Perold, Andre F., and Markus Mullarkey. "Morningstar, Inc." Harvard Business School Case 298-140, May 1998. (Revised February 2007.)
- November 2014 (Revised May 2017)
- Teaching Note
Fresno's Social Impact Bond for Asthma
By: John A. Quelch
The case desccribes a social impact bond (SIB) to fund home-based remediation programs designed to reduce asthma attacks among Fresno residents (especially children) and thereby save on health care costs (ambulance callouts, emergency room visits etc.). The case... View Details
- November 2012
- Teaching Note
Brink's Company: Activists Push for a Spin-off (TN)
By: Suraj Srinivasan
The case this Teaching Note addresses studies the decision of the security services company Brink's Corporation to spin off its home security division from the rest of the company. The decision followed intense pressure on the company by three activist hedge funds that... View Details
- 01 Mar 2024
- News
The Exchange: Takeaways from the Takedown
Professors Eugene Soltes and Aiyesha Dey; image by John Ritter When Sam Bankman-Fried was convicted in 2023 of all seven charges against him related to the cryptocurrency exchange FTX, the jury needed less than five hours to deliberate after a months-long trial. The... View Details
- 01 Jun 2016
- News
Imagine an Economy Without Wall Street
Photography by Bryce Vickmark In a recent opinion piece in the Wall Street Journal, HBS Dean Nitin Nohria made a strong statement in defense of Wall Street and the financial system. Recalling his youth in India, Nohria related the story of his father, a successful... View Details
- 01 Dec 2010
- News
Hardymon Receives VC Award
Felda Hardymon, the MBA Class of 1975 Professor of Management Practice, has received a Lifetime Achievement in Venture Capital Award from the National Venture Capital Association. A member of the HBS faculty for more than a decade, since 1981 Hardymon has also been a... View Details
- 13 Jul 2017
- Working Paper Summaries
Catering Through Disclosure: Evidence from Shanghai-Hong Kong Connect
Keywords: by Aaron S. Yoon